1. A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52). Issue 20 (25th June 2015) Authors: von Minckwitz, Gunter; Conrad, Bettina; Reimer, Toralf; Decker, Thomas; Eidtmann, Holger; Eiermann, Wolfgang; Hackmann, John; Möbus, Volker; Marmé, Frederik; Potenberg, Jochem; Stickeler, Elmar; Simon, Eike; Thomssen, Christoph; Huober, Jens; Denkert, Carsten; Alfer, Joachim; Jackisch, Christian;... Journal: Cancer Issue: Volume 121:Issue 20(2015) Page Start: 3639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA). Issue 4 (April 2019) Authors: Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph; Bauerschlag, Dirk O.; Costa, Serban-Dan; Herr, Daniel; Lübbe, Kristina; Marmé, Frederik; Maass, Nicolai; von Minckwitz, Gunter; Grischke, Eva-Maria; Müller, Volkmar; Schmidt, Marcus; Gerber, Bernd; Kümmel, Sherko; Schumacher, Claudia; Krabi... Journal: Anti-cancer drugs Issue: Volume 30:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A step towards a HER2-positive breast cancer super family. Issue 7 (July 2015) Authors: von Minckwitz, Gunter Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer. Issue 11 (25th November 2014) Authors: Marinovich, Michael Luke; Houssami, Nehmat; Macaskill, Petra; von Minckwitz, Gunter; Blohmer, Jens‐Uwe; Irwig, Les Journal: International journal of cancer Issue: Volume 136:Issue 11(2015:Jun. 01) Page Start: 2730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Issue 4 (April 2018) Authors: Loibl, Sibylle; O'Shaughnessy, Joyce; Untch, Michael; Sikov, William M; Rugo, Hope S; McKee, Mark D; Huober, Jens; Golshan, Mehra; von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark, Norman; McIntyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto; Rastogi, Priya; Symmans, W Fras... Journal: Lancet oncology Issue: Volume 19:Issue 4(2018) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. Issue 1 (December 2015) Authors: Marinovich, Michael; Macaskill, Petra; Irwig, Les; Sardanelli, Francesco; Mamounas, Eleftherios; von Minckwitz, Gunter; Guarneri, Valentina; Partridge, Savannah; Wright, Frances; Choi, Jae; Bhattacharyya, Madhumita; Martincich, Laura; Yeh, Eren; Londero, Viviana; Houssami, Nehmat Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Issue 10021 (27th February 2016) Authors: Forbes, John F; Sestak, Ivana; Howell, Anthony; Bonanni, Bernardo; Bundred, Nigel; Levy, Christelle; von Minckwitz, Gunter; Eiermann, Wolfgang; Neven, Patrick; Stierer, Michael; Holcombe, Chris; Coleman, Robert E; Jones, Louise; Ellis, Ian; Cuzick, Jack Journal: Lancet Issue: Volume 387:Issue 10021(2016) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapy. (1st November 2015) Authors: Fontanella, Caterina; Loibl, Sibylle; von Minckwitz, Gunter Journal: Breast Issue: Volume 24(2015)Supplement 2 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Developing an international network for breast cancer research: the BIG experience. (May 2011) Authors: Gnant, Michael; Piccart-Gebhart, Martine; Goldhirsch, Aron; Baselga, Jose; Cameron, David; Di Leo, Angelo; Dowsett, Mitchell; Gelber, Richard; von Minckwitz, Gunter; Waldvogel, Cecilia; Straehle, Carolyn Journal: Clinical investigation Issue: Volume 1:Number 5(2011) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial. Issue 7 (July 2018) Authors: von Minckwitz, Gunter; Colleoni, Marco; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia; Tomasevic, Zorica; Zhang, Nan; Hanes, Vladimir Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗